GSK’s First Biologic Treatment For Asthma – Nucala Holds Multi-Billion Dollar Potential – Seeking Alpha

GSK's First Biologic Treatment For Asthma – Nucala Holds Multi-Billion Dollar Potential
Seeking Alpha
Nucala was recently approved by the USFDA and EMA for the treatment of patients with severe Asthma of eosinophilic phenotype. In the base case, Nucala should reach peak sales of $2b. If Nucala is approved in other indications (COPD, HES) too, it can …

View full post on asthma – Google News

Quality improvement program helps asthma outcomes, saves $1.46 per dollar spent – Healthcare Finance News

Quality improvement program helps asthma outcomes, saves $1.46 per dollar spent
Healthcare Finance News
BOSTON – A program that provides home visits and education for families with children living with asthma has shown to dramatically reduce hospitalizations for the condition, meanwhile saving $1.46 in care for every $1 spent on prevention.

View full post on asthma – Google News

Million Dollar EPA Grant Powers Green Locomotive in …. – U.S. EPA.gov (press release)

Million Dollar EPA Grant Powers Green Locomotive in ….
U.S. EPA.gov (press release)
Locomotives are a source of pollutants in the outdoor air, including asthma triggers such as fine particles (soot) and ozone (smog). The new engines will reduce emissions of nitrogen oxide and particulate matter from the locomotive by 80 percent using

and more »

View full post on asthma – Google News